Membranous Lupus Nephritis: A Clinical Review

被引:29
作者
Almaani, Salem [1 ]
Parikh, Samir V. [1 ]
机构
[1] Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Div Nephrol, 395 W 12th Ave, Columbus, OH 43210 USA
关键词
Systemic lupus erythematosus; Lupus nephritis; Membranous lupus nephritis; Class V lupus nephritis; BLOOD-PRESSURE CONTROL; NEPHROTIC SYNDROME; CONTROLLED-TRIAL; DOUBLE-BLIND; ERYTHEMATOSUS PATIENTS; MYCOPHENOLATE-MOFETIL; KIDNEY-DISEASE; REPEAT BIOPSY; TERM; ALDOSTERONE;
D O I
10.1053/j.ackd.2019.08.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Membranous lupus nephritis (MLN) (Class V lupus nephritis [LN]) is a distinct form of LN defined by the presence of subepithelial immune complex deposits seen on kidney biopsy. MLN is often associated with the nephrotic syndrome. The histology of MLN closely resembles that of idiopathic (primary) membranous nephropathy (pMN). However, MLN typically has abundant mesangial deposits that are absent in primary membranous nephropathy. The clinical presentation, management, and prognosis of MLN differ from that of the proliferative forms of LN (Class III, IV, or Mixed III/IV + V). Although immunosuppressive therapy is often warranted in MLN, the optimal treatment regimen remains unclear. Here we describe the clinical presentation, histologic features, and natural history of MLN. We also review the role of supportive treatment and discuss when to deploy immunosuppressive management in MLN. (C) 2019 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:393 / 403
页数:11
相关论文
共 93 条
[1]  
ADLER SG, 1990, MODERN PATHOL, V3, P186
[2]  
Agrawal S, 2018, NAT REV NEPHROL, V14, P57, DOI 10.1038/nrneph.2017.155
[3]   Update on Lupus Nephritis [J].
Almaani, Salem ;
Meara, Alexa ;
Rovin, Brad H. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (05) :825-835
[4]  
[Anonymous], 1995, RENAL DIS CLASSIFICA
[5]  
[Anonymous], N ENGL J MED
[6]   RENAL INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - STUDY OF 56 PATIENTS EMPHASIZING HISTOLOGIC CLASSIFICATION [J].
APPEL, GB ;
SILVA, FG ;
PIRANI, CL ;
MELTZER, JI ;
ESTES, D .
MEDICINE, 1978, 57 (05) :371-410
[7]   Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease [J].
Appel, Lawrence J. ;
Wright, Jackson T., Jr. ;
Greene, Tom ;
Agodoa, Lawrence Y. ;
Astor, Brad C. ;
Bakris, George L. ;
Cleveland, William H. ;
Charleston, Jeanne ;
Contreras, Gabriel ;
Faulkner, Marquetta L. ;
Gabbai, Francis B. ;
Gassman, Jennifer J. ;
Hebert, Lee A. ;
Jamerson, Kenneth A. ;
Kopple, Joel D. ;
Kusek, John W. ;
Lash, James P. ;
Lea, Janice P. ;
Lewis, Julia B. ;
Lipkowitz, Michael S. ;
Massry, Shaul G. ;
Miller, Edgar R. ;
Norris, Keith ;
Phillips, Robert A. ;
Pogue, Velvie A. ;
Randall, Otelio S. ;
Rostand, Stephen G. ;
Smogorzewski, Miroslaw J. ;
Toto, Robert D. ;
Wang, Xuelei .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10) :918-929
[8]   Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies [J].
Arnaud, Laurent ;
Mathian, Alexis ;
Devilliers, Herve ;
Ruffatti, Amelia ;
Tektonidou, Maria ;
Forastiero, Ricardo ;
Pengo, Vittorio ;
Lambert, Marc ;
Lefevre, Guillaume ;
Martinez-Zamora, Maria Angeles ;
Balasch, Juan ;
Wahl, Denis ;
Amoura, Zahir .
AUTOIMMUNITY REVIEWS, 2015, 14 (03) :192-200
[9]   Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis [J].
Arnaud, Laurent ;
Mathian, Alexis ;
Ruffatti, Amelia ;
Erkan, Doruk ;
Tektonidou, Maria ;
Cervera, Ricard ;
Forastiero, Ricardo ;
Pengo, Vittorio ;
Lambert, Marc ;
Angeles Martinez-Zamora, Maria ;
Balasch, Juan ;
Zuily, Stephane ;
Wahl, Denis ;
Amoura, Zahir .
AUTOIMMUNITY REVIEWS, 2014, 13 (03) :281-291
[10]   Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy [J].
Austin, Howard A., III ;
Illei, Gabor G. ;
Braun, Michelle J. ;
Balow, James E. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (04) :901-911